Switch theme
Sign up to access all valuation multiples
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
1979
48.9K+
LTM Revenue $224B
LTM EBITDA $3.2B
$41.2B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Cardinal Health has a last 12-month revenue (LTM) of $224B and a last 12-month EBITDA of $3.2B.
In the most recent fiscal year, Cardinal Health achieved revenue of $227B and an EBITDA of $2.0B.
Cardinal Health expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Cardinal Health valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $224B | XXX | $227B | XXX | XXX | XXX |
| Gross Profit | $7.8B | XXX | $7.4B | XXX | XXX | XXX |
| Gross Margin | 3% | XXX | 3% | XXX | XXX | XXX |
| EBITDA | $3.2B | XXX | $2.0B | XXX | XXX | XXX |
| EBITDA Margin | 1% | XXX | 1% | XXX | XXX | XXX |
| EBIT | $2.7B | XXX | $2.1B | XXX | XXX | XXX |
| EBIT Margin | 1% | XXX | 1% | XXX | XXX | XXX |
| Net Profit | $2.0B | XXX | $852M | XXX | XXX | XXX |
| Net Margin | 1% | XXX | 0% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Cardinal Health's stock price is $154.
Cardinal Health has current market cap of $36.9B, and EV of $41.2B.
See Cardinal Health trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $41.2B | $36.9B | XXX | XXX | XXX | XXX | $8.07 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Cardinal Health has market cap of $36.9B and EV of $41.2B.
Cardinal Health's trades at 0.2x EV/Revenue multiple, and 16.0x EV/EBITDA.
Equity research analysts estimate Cardinal Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Cardinal Health has a P/E ratio of 18.8x.
See valuation multiples for Cardinal Health and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $36.9B | XXX | $36.9B | XXX | XXX | XXX |
| EV (current) | $41.2B | XXX | $41.2B | XXX | XXX | XXX |
| EV/Revenue | 0.2x | XXX | 0.2x | XXX | XXX | XXX |
| EV/EBITDA | 13.0x | XXX | 16.0x | XXX | XXX | XXX |
| EV/EBIT | 15.0x | XXX | 16.8x | XXX | XXX | XXX |
| EV/Gross Profit | 5.3x | XXX | n/a | XXX | XXX | XXX |
| P/E | 18.8x | XXX | 26.2x | XXX | XXX | XXX |
| EV/FCF | 25.6x | XXX | 17.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialCardinal Health's last 12 month revenue growth is 9%
Cardinal Health's revenue per employee in the last FY averaged $4.6M, while opex per employee averaged $0.1M for the same period.
Cardinal Health's rule of 40 is 9% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Cardinal Health's rule of X is 23% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Cardinal Health and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 9% | XXX | 6% | XXX | XXX | XXX |
| EBITDA Margin | 1% | XXX | 1% | XXX | XXX | XXX |
| EBITDA Growth | 12% | XXX | 41% | XXX | XXX | XXX |
| Rule of 40 | 9% | XXX | 10% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 23% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $4.6M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 2% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Ghitha Holding | XXX | XXX | XXX | XXX | XXX | XXX |
| Acomo | XXX | XXX | XXX | XXX | XXX | XXX |
| Sligro Food Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Metcash | XXX | XXX | XXX | XXX | XXX | XXX |
| Reece | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Cardinal Health acquired XXX companies to date.
Last acquisition by Cardinal Health was XXXXXXXX, XXXXX XXXXX XXXXXX . Cardinal Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Cardinal Health founded? | Cardinal Health was founded in 1979. |
| Where is Cardinal Health headquartered? | Cardinal Health is headquartered in United States of America. |
| How many employees does Cardinal Health have? | As of today, Cardinal Health has 48.9K+ employees. |
| Who is the CEO of Cardinal Health? | Cardinal Health's CEO is Mr. Jason M. Hollar. |
| Is Cardinal Health publicy listed? | Yes, Cardinal Health is a public company listed on NYS. |
| What is the stock symbol of Cardinal Health? | Cardinal Health trades under CAH ticker. |
| When did Cardinal Health go public? | Cardinal Health went public in 1994. |
| Who are competitors of Cardinal Health? | Similar companies to Cardinal Health include e.g. Ghitha Holding, Acomo, Sligro Food Group, Metcash. |
| What is the current market cap of Cardinal Health? | Cardinal Health's current market cap is $36.9B |
| What is the current revenue of Cardinal Health? | Cardinal Health's last 12 months revenue is $224B. |
| What is the current revenue growth of Cardinal Health? | Cardinal Health revenue growth (NTM/LTM) is 9%. |
| What is the current EV/Revenue multiple of Cardinal Health? | Current revenue multiple of Cardinal Health is 0.2x. |
| Is Cardinal Health profitable? | Yes, Cardinal Health is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Cardinal Health? | Cardinal Health's last 12 months EBITDA is $3.2B. |
| What is Cardinal Health's EBITDA margin? | Cardinal Health's last 12 months EBITDA margin is 1%. |
| What is the current EV/EBITDA multiple of Cardinal Health? | Current EBITDA multiple of Cardinal Health is 13.0x. |
| What is the current FCF of Cardinal Health? | Cardinal Health's last 12 months FCF is $1.6B. |
| What is Cardinal Health's FCF margin? | Cardinal Health's last 12 months FCF margin is 1%. |
| What is the current EV/FCF multiple of Cardinal Health? | Current FCF multiple of Cardinal Health is 25.6x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
